ClinicalTrials.Veeva

Menu
C

Center for Clinical and Cosmetic Research | Aventura, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

STP705
aminolevulinic acid hydrochloride
ALA HCl
BBI-4000
Aminolevulinic Acid
ALA
ACZONE
Remlarsen
Dapsone
HTU-520

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 28 total trials

A Study to Evaluate AI-09 In Participants With Glabellar Lines

Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of AI-09, a Ready-to-Use Liquid Injectable Botulinum Toxin.

Active, not recruiting
Glabellar Lines
Biological: AI-09 Ready Use Injectable Botulinum Toxin
Biological: Vehicle

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Enrolling
Prurigo Nodularis
Drug: Placebo
Drug: Povorcitinib

This Phase 3, randomized, multi-center, evaluator-blind, vehicle-controlled study evaluates the efficacy and safety of reformulated Levulan Kerastick...

Active, not recruiting
Actinic Keratosis
Drug: Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%
Device: Blue Light Photodynamic Therapy Illuminator device, BLU-U® model 4170E

This Phase 3, randomized, multi-center, evaluator-blind, vehicle-controlled study evaluates the efficacy and safety of reformulated Levulan Kerastick...

Active, not recruiting
Actinic Keratosis
Drug: Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%
Device: Blue Light Photodynamic Therapy Illuminator device, BLU-U® model 4170E.

Trial sponsors

S
T
B
C
D
Galderma logo
S
Almirall logo
E
H

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems